Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MBX
MBX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MBX News
MBX Biosciences Shares Drop After Trial Results Fall Short
Jun 12 2026
seekingalpha
MBX Biosciences Reports Canvuparatide Clinical Trial Results
Jun 12 2026
Newsfilter
Biotech Companies See Significant Stock Gains
Jun 12 2026
NASDAQ.COM
MBX Biosciences CMO Sells 70,003 Shares for $2.69 Million
May 27 2026
Fool
MBX Biosciences CMO Sells 70,003 Shares for $2.69 Million
May 27 2026
NASDAQ.COM
UBS Sees 50% Upside for MBX Biosciences Stock
May 12 2026
CNBC
MBX Biosciences Reports Q1 Financial Results
May 07 2026
seekingalpha
Potential Analysis of Small Biotech Stocks
May 05 2026
Fool
Aaron Wealth Advisors Increases Stake in MBX Biosciences
Apr 22 2026
Fool
Microbix Releases New Episodes of 'Diagnostics: Beyond the Lab' Podcast
Apr 20 2026
Yahoo Finance
MBX Biosciences CEO Increases Shareholding
Mar 26 2026
Fool
MBX Biosciences Reports Q4 2025 Financial Results
Mar 12 2026
seekingalpha
Mbx Biosciences Shares Hit Oversold Signal
Mar 09 2026
NASDAQ.COM
MBX Biosciences Completes EOP2 Meeting with FDA for Canvuparatide
Mar 09 2026
Newsfilter
MBX Biosciences Completes FDA Meeting, Advances New Drug Trial
Mar 09 2026
Newsfilter
Overview of 13D Filings
Feb 21 2026
Yahoo Finance
Show More News
